• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Antibody dependent enhancement-induced hypoxic respiratory failure: A case report.

作者信息

Elfessi Zane, Doyle Richard, Young Lisa, Knaub Mark, Yamanaka Travis

机构信息

Department of Emergency Medicine, Jesse Brown Veterans Affairs Medical Center, 820 S Damen Avenue, Chicago, IL 60612, United States.

Department of Pharmacy Practice, University of Illinois-Chicago College of Pharmacy, 833 S Wood Street, Chicago, IL 60612, United States.

出版信息

Vis J Emerg Med. 2023 Jan;30:101602. doi: 10.1016/j.visj.2023.101602. Epub 2023 Jan 26.

DOI:10.1016/j.visj.2023.101602
PMID:36718416
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9876737/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f838/9876737/22f75fb1476a/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f838/9876737/04362ed8dde8/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f838/9876737/22f75fb1476a/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f838/9876737/04362ed8dde8/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f838/9876737/22f75fb1476a/gr2_lrg.jpg

相似文献

1
Antibody dependent enhancement-induced hypoxic respiratory failure: A case report.抗体依赖增强作用所致的缺氧性呼吸衰竭：一例报告
Vis J Emerg Med. 2023 Jan;30:101602. doi: 10.1016/j.visj.2023.101602. Epub 2023 Jan 26.
2
SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19.SARS-CoV-2 中和单克隆抗体预防 COVID-19。
Cochrane Database Syst Rev. 2022 Jun 17;6(6):CD014945. doi: 10.1002/14651858.CD014945.pub2.
3
Effect of timing of casirivimab and imdevimab administration relative to mRNA-1273 COVID-19 vaccination on vaccine-induced SARS-CoV-2 neutralising antibody responses: a prospective, open-label, phase 2, randomised controlled trial.卡西瑞维单抗和英地维单抗给药时间相对于mRNA-1273 COVID-19疫苗接种时间对疫苗诱导的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）中和抗体反应的影响：一项前瞻性、开放标签、2期随机对照试验。
Lancet Infect Dis. 2025 Jan;25(1):52-67. doi: 10.1016/S1473-3099(24)00421-3. Epub 2024 Sep 2.
4
Breakthrough COVID-19 and casirivimab-imdevimab treatment during a SARS-CoV-2 B1.617.2 (Delta) surge.突破性 COVID-19 与 SARS-CoV-2 B.1.617.2 (Delta) 变异株流行期间使用 casirivimab-imdevimab 治疗
J Clin Virol. 2021 Dec;145:105026. doi: 10.1016/j.jcv.2021.105026. Epub 2021 Nov 8.
5
Virologic Efficacy of Casirivimab and Imdevimab COVID-19 Antibody Combination in Outpatients With SARS-CoV-2 Infection: A Phase 2 Dose-Ranging Randomized Clinical Trial.司鲁利单抗和度伐利尤单抗联合治疗 COVID-19 抗体在门诊 SARS-CoV-2 感染患者中的病毒学疗效：一项 2 期剂量范围随机临床试验。
JAMA Netw Open. 2022 Aug 1;5(8):e2225411. doi: 10.1001/jamanetworkopen.2022.25411.
6
Clinical efficacy of casirivimab-imdevimab antibody combination treatment in patients with COVID-19 Delta variant.卡司瑞韦单抗-伊德韦单抗抗体联合治疗 COVID-19 德尔塔变异株患者的临床疗效。
J Infect Chemother. 2022 Sep;28(9):1344-1346. doi: 10.1016/j.jiac.2022.05.012. Epub 2022 May 26.
7
Real-world effect of casirivimab and imdevimab cocktail in patients infected with SARS-CoV-2 delta and omicron variants.卡司瑞韦单抗和伊米替韦单抗鸡尾酒疗法对感染 SARS-CoV-2 德尔塔和奥密克戎变异株患者的真实世界疗效。
J Infect Dev Ctries. 2023 Mar 31;17(3):293-301. doi: 10.3855/jidc.17039.
8
Effectiveness of casirivimab/imdevimab in an intensive care unit patient with acute respiratory failure due to SARS-CoV-2 infection.卡西瑞维单抗/伊德维单抗对一名因感染SARS-CoV-2导致急性呼吸衰竭的重症监护病房患者的疗效。
Proc (Bayl Univ Med Cent). 2022 Mar 3;35(3):339-341. doi: 10.1080/08998280.2022.2042033. eCollection 2022.
9
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.卡司瑞韦单抗和伊德韦单抗联合治疗住院 COVID-19 患者（RECOVERY）：一项随机、对照、开放标签、平台试验。
Lancet. 2022 Feb 12;399(10325):665-676. doi: 10.1016/S0140-6736(22)00163-5.
10
Impact of COVID vaccine and comorbidities in patients receiving casirivimab-imdevimab monoclonal antibody during SARS-CoV-2 B.1.617.2 (Delta) surge: A real-world study.新冠病毒 B.1.617.2（德尔塔）变异株流行期间接受 casirivimab-imdevimab 单克隆抗体治疗的患者中新冠疫苗和合并症的影响：一项真实世界研究。
Vaccine. 2023 Aug 7;41(35):5195-5200. doi: 10.1016/j.vaccine.2023.07.011. Epub 2023 Jul 13.

引用本文的文献

1
FcγRIIa-mediated antibody-dependent uptake of SARS-CoV-2 enhances IL-6 expression of monocytes.FcγRIIa介导的严重急性呼吸综合征冠状病毒2抗体依赖性摄取增强单核细胞白细胞介素-6表达。
Eur J Microbiol Immunol (Bp). 2024 Dec 16;14(4):380-391. doi: 10.1556/1886.2024.00109. Print 2024 Dec 18.
2
Non-RBD peptides of SARS-CoV-2 spike protein exhibit immunodominance as they elicit both innate and adaptive immune responses.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）刺突蛋白的非受体结合域（Non-RBD）肽表现出免疫优势，因为它们能引发先天性和适应性免疫反应。
Heliyon. 2024 Oct 29;10(21):e39941. doi: 10.1016/j.heliyon.2024.e39941. eCollection 2024 Nov 15.
3

本文引用的文献

1
Anti-SARS-CoV2 antibody-mediated cytokine release syndrome in a patient with acute promyelocytic leukemia.抗 SARS-CoV-2 抗体介导的细胞因子释放综合征在急性早幼粒细胞白血病患者中的表现。
BMC Infect Dis. 2022 Jun 13;22(1):537. doi: 10.1186/s12879-022-07513-0.
2
Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou, China.中国广州新型严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）德尔塔变异株（VOC）的传播、病毒动力学及临床特征
EClinicalMedicine. 2021 Oct;40:101129. doi: 10.1016/j.eclinm.2021.101129. Epub 2021 Sep 12.
3
Antibody-Dependent Enhancement of Ebola Virus Infection by Human Antibodies Isolated from Survivors.
A Review: Understanding Molecular Mechanisms of Antibody-Dependent Enhancement in Viral Infections.
综述：理解病毒感染中抗体依赖增强作用的分子机制
Vaccines (Basel). 2023 Jul 14;11(7):1240. doi: 10.3390/vaccines11071240.
幸存者体内分离得到的人源抗体增强埃博拉病毒感染的抗体依赖性增强作用
Cell Rep. 2018 Aug 14;24(7):1802-1815.e5. doi: 10.1016/j.celrep.2018.07.035.
4
50 Years Ago in The Journal of Pediatrics: Atypical Exanthem after Exposure to Natural Measles: Eleven Cases in Children Previously Inoculated with Killed Vaccine.50年前发表于《儿科学杂志》：接触自然麻疹后出现的非典型皮疹：11例曾接种灭活疫苗的儿童病例
J Pediatr. 2018 Feb;193:84. doi: 10.1016/j.jpeds.2017.12.036.
5
Cross-reacting antibodies enhance dengue virus infection in humans.交叉反应抗体增强了人类感染登革热病毒的能力。
Science. 2010 May 7;328(5979):745-8. doi: 10.1126/science.1185181.
6
A method for estimating the probability of adverse drug reactions.一种估算药物不良反应概率的方法。
Clin Pharmacol Ther. 1981 Aug;30(2):239-45. doi: 10.1038/clpt.1981.154.
7
Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine.尽管之前接种了抗原性灭活疫苗，但婴儿仍患呼吸道合胞病毒病。
Am J Epidemiol. 1969 Apr;89(4):422-34. doi: 10.1093/oxfordjournals.aje.a120955.
8
Flavivirus infection enhancement in macrophages: an electron microscopic study of viral cellular entry.
J Gen Virol. 1985 Sep;66 ( Pt 9):1969-82. doi: 10.1099/0022-1317-66-9-1969.